Codon Biotech Private Limited - Due diligence report

A 360° intelligence report on Codon Biotech Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2007-05-11 Delhi, Delhi Converted To Llp Unlisted Active Compliant
Share
View plans
CB Codon Biotech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Codon Biotech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
63/100
Trust Score
Moderate

Codon Biotech Private Limited is assessed as Moderate with a Trust Score of 63/100. Codon Biotech Private Limited is a private limited indian non-government company incorporated in 2007, operating in the Life Sciences sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 27 Jun 2026 from the latest processed filings. Codon Biotech Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
63/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 30/100 Caution Indicated
  • Company status is "Converted To Llp" - not Active.
  • Last balance sheet is for Mar 2022 - filings overdue.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
OM PRAKESH LAL 01234567 Director 01/04/2018 6 yrs Approved
TRIPTI BHATNAGAR 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 55
Growth signals & trust indicators
Latest year revenue grew 1.42.
Operating for 19+ years.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Converted To Llp.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence47/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment56/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view60/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2022
Last AGM held
Annual general meeting
31 Mar 2022
Latest balance sheet
Filed with ROC
13 Apr 2019
Director ceased
AKHILESH KUMAR BHATNAGAR
31 Mar 2016
Share transfer (FY 2016)
5000.00000000 shares to Prakesh Lal
Share transfer (FY 2016)
123650.00000000 shares to Tripti
25 Mar 2016
Director ceased
MADHU SRIVASTAVA
31 Mar 2014
Director ceased
RAJNI KANT SRIVASTAVA
20 Mar 2012
Securities allotted
13650 Equity Shares Without Differential Rights - 27.30 Lakh raised
30 Mar 2011
Securities allotted
197000 Equity Shares Without Differential Rights - 19.70 Lakh raised
21 Dec 2010
Director appointed
OM PRAKESH LAL (Director)
31 Mar 2010
Securities allotted
40000 Equity Shares Without Differential Rights - 4.00 Lakh raised
01 Sep 2007
Director appointed
TRIPTI BHATNAGAR (Director)
11 May 2007
Incorporated
Registered with Roc Delhi
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Chema Polymer Private Limited U25209WB2005PTC104019 Kolkata, West Bengal, India
Kaushik Associates U63090WB1989PTC047395 Kolkata, West Bengal, India
Senmorta Technologies Private Limited U74999GJ2018PTC100764 Ahmedabad, Gujarat, India
Arcata Petroleum Private Limited U11201GJ2009PTC058388 Ahmedabad, Gujarat, India
Powerful Impex Private Limited U99999MH1996PTC104056 Mumbai, Maharashtra, India
Lutfi Optronics Private Limited U74900WB2012PTC189426 Kolkata, West Bengal, India
Medialogy Broadcast Private Limited U52590DL2022PTC392216 Delhi, Delhi, India
Riveram India Private Limited U10304MH2020PTC338818 Kalyan, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Codon Biotech Private Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Codon Biotech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Codon Biotech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 63/100, distress signals and MSME payment-delay disclosures - know whether Codon Biotech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Codon Biotech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Codon Biotech Private Limited an active company?

Codon Biotech Private Limited has MCA status “Converted To Llp” with a compliance score of 30/100 (Caution Indicated).

Is Codon Biotech Private Limited financially healthy?

Codon Biotech Private Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Codon Biotech Private Limited?

Its overall Trust Score is 63/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Codon Biotech Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Codon Biotech Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Codon Biotech Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Codon Biotech Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.